Aviva Group

Allianz

MetLife

AXA Group

Prudential Financial

Empowering sustainable food innovation through food engineering tech

Alternative Ingredients

Alkion BioInnovations (formerly Alkion BioPharma) is a French startup developing a patented biostimulation process to produce sweet proteins for the agri-food and nutraceutical markets. The company was formed following the acquisition of Alkion BioPharma by Evonik Industries in March 2017, with a focus on developing pharmaceutical and agri-food solutions.The process involves plant tissue culture in bioreactors, resulting in the growth of stable callus that serves as the basis for growing specific plant organs responsible for sweet protein production. The company's natural sweetener, derived from Mabinlin II in the Capparis Masaaki plant, is 300x sweeter than sugar. Its sweetener portfolio also includes thaumatin, brazzein, pentadin, and stevia. The company also focuses on producing flavors like vanillin, saffron, nootkatone, valencene, and plant proteins like duckweed (Lemna).As of October 2023, all of Alkion BioInnovations' food ingredients were at the proof-of-concept stage. The company aimed to produce ten tons of sweet proteins per year during the initial industrialization phase.Key customers and partnershipsFrom January 2019 to December 2020, Alkion BioInnovations collaborated with FranceAgrimer, a national agriculture agency, and received a EUR 718,000 (~USD 760,756) grant for its NeSweetGen program. The program focused on two sweetener production methods: biostimulation of Capparis biomass in bioreactors and recombinant protein production.Funding and financialsIn June 2022, Alkion secured a EUR 5 million (~USD 5.3 million) grant from the European Commission as part of the EIC Accelerator to establish a pilot biorefinery for large-scale production of recombinant proteins.

Biologically protecting plants from pests

Biopesticides

Alkion BioInnovations is a biotechnology company that develops an industrial process for producing compounds of interest through the biostimulation of plant cells. Their technology enables the substitution of chemical additives with natural alternatives in the food industry. The company's process involves dedifferentiating plant cells and then redifferentiating them into cells that produce desired secondary metabolites. This is achieved through biostimulation in bioreactors by inducing biotic and abiotic stress on the cells, as well as other specific approaches like transient (non-GMO) expression.
Alkion BioInnovations aims to increase the production of a secondary metabolite of interest by a cell by 2,000 times, compared to 800 times during the Alkion BioPharma era. The company holds two exclusive licenses on patents - one for the production method and another for large-scale bioreactor production. They plan to patent applications on a case-by-case basis. As of 2018, the startup could produce compounds in 50-liter bioreactors and aimed to scale up to 300 liters by the end of 2018. Their bioreactor technology integrates robotics and artificial intelligence to better analyze and control cellular processes.
Alkion BioInnovations targets the production of various plant-based food ingredients, including natural sweeteners, flavors (vanilla, saffron), natural colorants, flavor enhancers, and plant-based proteins. In March 2018, they identified a high-sweetening protein with the potential to replace sugar.

Nattergal operates as a nature restoration company.

Feroscan was set up in 2014 at the initiative of its four founders bringing together scientific and business skills. Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian, triple negative breast  and NSCL cancers. Feroscan’s business strategy is to test in parallel several preclinical programs on several orphan applications up to proof of concept, IND and early clinical stages. Feroscan is based on a strong IP strategy, cutting edge science and relies on a strong academic and industrial network worldwide to develop clinical applications of its research programs.

Alkion BioInnovations was created in March 2017 in order to develop disruptive cannabinoid & pharmaceutical API production using large scale plant tissue production.  The team works also on a new sugar replacement: a novel plant-based high intensive protein sweetener.  The company won many R&D grants: I-lab, I-Nov, Plan de Relance & EIC Phase I; and other prize: La Fabrique Aviva, Netva, Wilco, IPA4SME...

Trackinsight provides investors with data, tools and analysis on ETFs listed worldwide.   Trackinsight provides curated daily data on over 7,000 exchange-traded funds (ETFs) listed worldwide, supports the due diligence and ETF research needs of professional investors and creates bespoke technology solutions for ETF and capital market participants.   Trackinsight is a privately held financial technology company founded in 2014 with operations in USA, Canada, France, Netherlands, Switzerland, and United Kingdom.

Claim Assistance owns and operates refundmyticket.com and remboursermonbillet.com that help travelers claim air transport related refunds. It has developed tools, databases, algorithms and processes to optimize and industrialize air passenger claims for delayed or cancelled flights. They use them for individuals but indeed for corporate partnerships like OTA, metasearch companies or corporate travel platforms.  Pierrick Morier and Romain Drosne founded RefundMyTicket in 2014. It has its headquarters in Pantin in France.

Founders Factory builds and funds startups together with exceptional entrepreneurs and the world's leading companies. We invest across four key themes - fintech, health, climate, and deeptech. Founded in 2015 by Brent Hoberman, Henry Lane Fox and George Northcott, Founders Factory combines capital and bespoke support from a team of over 70 specialists with a broad network of corporates and established entrepreneurs. Founders Factory has backed over 300 technology companies globally. Corporate partners include Aviva, L’Oreal, Guardian Media Group, easyJet, Reckitt, Marks and Spencer, CSC Group, J&J, Deutsche Telekom, Fastweb, Pico Global, Mediobanca and Standard Bank.

Aviva is a British multinational insurance company headquartered in London, United Kingdom. It is the sixth-largest insurance company in the world measured by net premium income and has around 43 million customers across 21 countries. Aviva is the market leader in both general insurance and life and pensions in the UK and has major businesses in Asia, continental Europe and North America. They offer a wide range of insurance and savings products to help people protect what’s important to them and save for a comfortable future. They help them to defy uncertainty. They believe they have a clear strategic advantage: they are a ''composite'' insurer, which means they can provide customers with a wide range of insurance and savings products - from car, home and health insurance to pensions, investments and asset management. They are the UK’s largest insurer and they also have a strong international presence in Europe, Canada and Asia. They focus on markets where they can achieve scale, profitability and competitive advantage.

<div> Aviva (LON: AV) is a British insurance company providing life insurance, general and health insurance, and fund management services. Aviva is the largest life insurer in the UK with a <a href="https://www.aviva.com/about-us/how-we-are-organised/"> market share of ~23% </a> as of December 2023. It has been listed on the&nbsp; London Stock Exchange since <a href="https://www.londonstockexchange.com/stock/AE57/aviva-plc/company-page"> 2002 </a> and generated revenue of GBP 18.5 billion (USD ~21 billion) and GWPs of GBP 10.9 billion (USD ~14 billion) in 2023. Aviva operates under three main business segments: The General insurance and health segment is the largest (~59% of insurance revenue in 2023) and offers insurance coverage for individuals and businesses. The Long-term business segment (~41%) comprises life insurance, long-term health and accident insurance, savings, pensions, and annuity businesses. The Fund management segment engages in fund management services for both policyholders and shareholders while offering investment management services to institutional pension fund mandates.&nbsp; As of 2023, Aviva has approximately <a href="https://www.aviva.com/about-us/how-we-are-organised/"> 19.2 million insurance customers </a> in the UK, Ireland, and Canada. Aviva&rsquo;s financial targets over 2024&ndash;2026 include 1) GBP 2 billion of adjusted operating profit by 2026; 2) GBP 1.8 billion Solvency II operating own funds by 2026; and 3) over GBP 5.8 billion in cumulative cash remittances by 2024&ndash;2026. The company is committed to achieving net-zero emissions by 2040. </div>

AVIVA

Aviva Investors Teams Up With Octopus Energy to Provide 'Zero Bills' Tariff to 48 Milton Keynes Homes .. aviva group;octopus energy . partner

New insurance models are disrupting a centuries-old industry with a focus on personalization and convenience

InsurTech: Personal Lines

Startups in the automobile insurance space, predominantly providing usage-based insurance using telematics devices and/or smartphone sensors.

Startups that offer homeowners and renters insurance using artificial intelligence (AI) and smart home devices to issue policies and validate claims.

Startups that provide life insurance through digital channels personalized to an individual’s circumstances and replacing traditional practices, such as medical tests, with data-driven underwriting.

Companies that offer personal line covers for travel and pets through digital channels and use technologies such as flight tracking and online claims processing.

Providers of comparison websites and tools for carriers, agents, and consumers to compare and purchase policies.

Companies that provide personalized health insurance to consumers via digital channels and use technology such as wearable medical devices to monitor health and improve user experience and underwriting.

Companies that offer digital-only insurance for personal belongings (bicycles, mobile phones, laptops, and cameras), providing protection against theft, loss, or damage, with financial reimbursement or replacement.

The latest line of defense against rising cyber attacks

Cyber Insurance

Provides cyber insurance as a core product, often bundled with cybersecurity solutions and a team that assists in detection and response

Provides commercial property and casualty insurance products with cyber insurance as an additional product offering

Provides solutions for insurers/brokers to obtain an overview of security health and risk exposure for potential and existing clients

Provides solutions for insurers that use AI-based approaches and predictive models to quantify the financial impact of cyber risks

INCUMBENTS_PRESENT

PROMINENT_CATEGORY

<div>
 
 Insurance provider Aviva has launched a new telematics-based auto insurance service, Aviva MyDrive, available as a free add-on to customers purchasing Aviva's Online car insurance through a price comparison website. The service aims to encourage safer driving habits in users and potentially offers reduced insurance premiums as a reward.
 The Aviva MyDrive app uses smartphone data to assess the driving behaviour of its users, taking into consideration acceleration, braking intensity, cornering technique, speed, and phone use while at the wheel.&nbsp;
 Aviva has stated that approximately 85% of Aviva MyDrive users are likely to receive a discount on their next insurance renewal based on their recorded driving habits.
 
</div>

AVIVA

Featured Industries

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless